When comparing the presence of the three studied pathways, we found that compared to mTORC1 and STAT, the activation of the NLRP3 inflammasome pathway had both the highest prevalence (85%) and IHC score (4.27 ± 2.60) in patients with sarcoidosis at diagnosis. The gene discussed is NLRP3; the disease is sarcoidosis.